A detailed history of Israel Englander (Millennium Management LLC) transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 17,344 shares of CADL stock, worth $92,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,344
Holding current value
$92,443
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.68 - $14.0 $29,137 - $242,816
17,344 New
17,344 $107,000
Q3 2022

Nov 14, 2022

BUY
$3.05 - $4.08 $45,274 - $60,563
14,844 New
14,844 $47,000

Others Institutions Holding CADL

About Candel Therapeutics, Inc.


  • Ticker CADL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,891,900
  • Market Cap $154M
  • Description
  • Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...
More about CADL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.